Shattuck Labs STTK Stock
0.85 USD
{{ price }}
-10.967267%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
40.52M USD
LOW - HIGH [24H]
0.85
-
1 USD
VOLUME [24H]
152.5K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.49 USD
Shattuck Labs Price Chart
Shattuck Labs STTK Financial and Trading Overview
| Shattuck Labs stock price | 0.85 USD |
| Previous Close | 2.82 USD |
| Open | 2.81 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 2.71 - 2.85 USD |
| 52 Week Range | 1.85 - 5.82 USD |
| Volume | 55.92K USD |
| Avg. Volume | 33.15K USD |
| Market Cap | 118.07M USD |
| Beta (5Y Monthly) | 1.092489 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.49 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.6 USD |
STTK Valuation Measures
| Enterprise Value | -11711968 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.4111675 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 166.53062 |
| Price/Book (mrq) | 0.7487207 |
| Enterprise Value/Revenue | -16.519 |
| Enterprise Value/EBITDA | 0.12 |
Trading Information
Shattuck Labs Stock Price History
| Beta (5Y Monthly) | 1.092489 |
| 52-Week Change | -18.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.82 USD |
| 52 Week Low | 1.85 USD |
| 50-Day Moving Average | 2.84 USD |
| 200-Day Moving Average | 2.97 USD |
STTK Share Statistics
| Avg. Volume (3 month) | 33.15K USD |
| Avg. Daily Volume (10-Days) | 15.88K USD |
| Shares Outstanding | 42.47M |
| Float | 28.55M |
| Short Ratio | 7.79 |
| % Held by Insiders | 19.33% |
| % Held by Institutions | 48.47% |
| Shares Short | 269.01K |
| Short % of Float | 0.97% |
| Short % of Shares Outstanding | 0.63% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -14220.59% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.12% |
| Return on Equity (ttm) | -48.27% |
Income Statement
| Revenue (ttm) | 709K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -82247000 USD |
| EBITDA | -97209000 USD |
| Net Income Avi to Common (ttm) | -98141000 USD |
| Diluted EPS (ttm) | -2.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 135.5M USD |
| Total Cash Per Share (mrq) | 3.19 USD |
| Total Debt (mrq) | 4.01M USD |
| Total Debt/Equity (mrq) | 2.55 USD |
| Current Ratio (mrq) | 9.859 |
| Book Value Per Share (mrq) | 3.713 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -94682000 USD |
| Levered Free Cash Flow (ttm) | -68746000 USD |
Profile of Shattuck Labs
| Country | United States |
| State | TX |
| City | Austin |
| Address | 500 West 5th Street |
| ZIP | 78701 |
| Phone | 512 900 4690 |
| Website | https://www.shattucklabs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 105 |
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Q&A For Shattuck Labs Stock
What is a current STTK stock price?
Shattuck Labs STTK stock price today per share is 0.85 USD.
How to purchase Shattuck Labs stock?
You can buy STTK shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shattuck Labs?
The stock symbol or ticker of Shattuck Labs is STTK.
Which industry does the Shattuck Labs company belong to?
The Shattuck Labs industry is Biotechnology.
How many shares does Shattuck Labs have in circulation?
The max supply of Shattuck Labs shares is 47.9M.
What is Shattuck Labs Price to Earnings Ratio (PE Ratio)?
Shattuck Labs PE Ratio is now.
What was Shattuck Labs earnings per share over the trailing 12 months (TTM)?
Shattuck Labs EPS is -1.49 USD over the trailing 12 months.
Which sector does the Shattuck Labs company belong to?
The Shattuck Labs sector is Healthcare.
Shattuck Labs STTK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17449.89 USD — |
+0.87
|
6.97B USD — | 17149.36 USD — | 17506.58 USD — | — - | 6.97B USD — |
| NASDAQ Global Select Market Com NQGS | 8541.08 USD — |
+0.91
|
— — | 8392.44 USD — | 8567.09 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4132.89 USD — |
-2.63
|
— — | 4122.19 USD — | 4247.3 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 929.13 USD — |
-1.85
|
— — | 925.14 USD — | 947.12 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4486.38 USD — |
-0.37
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}